SCHEMBL1928683

SCHEMBL1928683

CCOC(=O)C1=C(C(F)(F)C(F)(F)F)NC(=O)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.44
KMT2A Q03164 4/20 0.44
MAPT P10636 3/20 0.44
MEN1 O00255 2/20 0.44
ALOX15 P16050 1/20 0.44
CYP1A2 P05177 1/20 0.38
POLB P06746 1/20 0.37
ALDH1A1 P00352 5/20 0.36
HTT P42858 1/20 0.36
ADORA2B P29275 2/20 0.36
MTOR P42345 1/20 0.35
RAB9A P51151 1/20 0.35
HIF1A Q16665 1/20 0.35
LMNA P02545 2/20 0.34
TDP1 Q9NUW8 1/20 0.33
AGTR1 P30556 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
BRD4 O60885 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3412296 0.88 KDM4E (0.46) KDM4EKMT2AMAPTMEN1ALOX15
SCHEMBL4248485 0.77 KDM4E (0.62) KDM4EKMT2AMAPTMEN1ALOX15
SCHEMBL9631901 0.74 KDM4E (0.50) KDM4EKMT2AMAPTMEN1ALOX15
SCHEMBL5608026 0.70 KDM4E (0.59) KDM4EKMT2AMAPTMEN1ALOX15
SCHEMBL11035853 0.69 KDM4E (0.61) KDM4EKMT2AMAPTMEN1ALOX15
SCHEMBL11040347 0.67 KDM4E (0.50) KDM4EKMT2AMAPTMEN1ALOX15
SCHEMBL5449876 0.65 KDM4E (0.76) KDM4EKMT2AMAPTMEN1ALOX15
SCHEMBL5954131 0.65 KDM4E (0.53) KDM4EKMT2AMAPTMEN1ALOX15
SCHEMBL1626805 0.65 KDM4E (0.53) KDM4EKMT2AMAPTMEN1ALOX15
Diethyl Phthalate SCHEMBL28264903 0.65 TSHR (0.70) KDM4EKMT2AMAPTMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7956070-B2 Piperidines as chemokine modulators (CCR) ASTRAZENECA AB (SE) 2011-06-07 US disclosed
US-20070054924-A1 Novel piperidines as chemokine modulators (ccr) ASTRAZENECA AB (SE) 2007-03-08 US disclosed
EP-1713772-A1 NOVEL PIPERIDINES AS CHEMOKINE MODULATORS (CCR) AstraZeneca AB (SE) 2006-10-25 EP disclosed
WO-2005073192-A1 NOVEL PIPERIDINES AS CHEMOKINE MODULATORS (CCR) ASTRAZENECA AB (SE) 2005-08-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070054924-A1 Novel piperidines as chemokine modulators (ccr) CCR3, CCR1, CCR4 KDM4E 3873/4885KMT2A 4417/4885MAPT 4473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.